New York, New York: Dupixent Lawsuits

Jed Dietrich, Esq., Recognized as a Super Lawyer and Lawyer of Distinction, is Committed to Providing Unparalleled Personal Injury Service. If You or a Loved One Has Been Diagnosed with Cutaneous T-Cell Lymphoma After Taking Dupixent, the Dietrich Law Firm P.C. Could Help You Assert Your Rights to a Fair Recovery.

Dupixent is a biologic medication that is most frequently used in the treatment of asthma, eczema, and other types of atopic dermatitis. One of Dupixent’s greatest benefits is that it was designed to target the immune system processes that cause eczema and asthma-related inflammation. By binding to and blocking certain protein receptors, Dupixent can relieve inflammation from inside the body.

However, some researchers believe that Dupixent’s mechanism of action could have a serious downside.

According to a recent series of reports, people who take Dupixent to manage eczema and acute dermatitis are much more likely to be diagnosed with cutaneous T-cell lymphoma (CTCL) than patients who take other medications. Nobody understands exactly why this relationship exists, but one common theory posits that, by controlling inflammation, Dupixent can effectively “mask” the most common early-warning signs of cancer. This is because CTCL’s most common subtype, mycosis fungoides, can be near-indistinguishable from ordinary cases of eczema. By suppressing symptoms, Dupixent could make it more difficult to obtain an accurate diagnosis and, by extension, life-saving medical care.

Under state and federal law, pharmaceutical companies have a duty to warn patients of potential side effects and complications. But most people who were prescribed Dupixent were never told that their eczema treatment could carry an increased risk for cancer.

If you or a loved one has been diagnosed with CTCL after taking Dupixent, you could be entitled to significant compensation. A recognized U.S. News & World Report Best Law Firm, the Dietrich Law Firm P.C. has spent decades helping New York families assert their rights to a fair recovery. Call Jed Dietrich, Esq., today at 1-866-529-5334 to speak to a Dupixent cancer lawyer in New York and find out how much your case could be worth.

You could be entitled to file a Dupixent cancer lawsuit if you meet the following conditions:

1. You were prescribed Dupixent for eczema, asthma, or another approved use;
2. You were diagnosed with cutaneous T-cell lymphoma after taking Dupixent; and
3. You were not diagnosed with a condition like Hodgkin’s lymphoma, non-Hodgkin lymphoma, or leukemia before starting Dupixent.

However, even if you meet these conditions, you must be prepared to fight an uphill battle.

Pharmaceutical companies like Regeneron and Sanofi, the makers of Dupixent, are corporate enterprises that prioritize profits, potentially to your detriment. Since scientists are still investigating the nature of the relationship between Dupixent and cutaneous T-cell lymphoma, you can and should expect the defendant companies to aggressively push back on your claim, potentially even arguing that there is too little evidence to conclude that your cancer was most likely caused by their medications.

If you think that you could have a case agaist Regeneron, Sanofi, or another pharmaceutical company, you likely stand your best chance of recovery with an experienced personal injury lawyer in your corner. However, you do not have to wait for your initial consultation to begin building a strong case. Instead, you could get a head start by:

Scientists have already uncovered compelling evidence of a relationship between Dupixent and cutaneous T-cell lymphoma, but research studies alone cannot win a lawsuit.

You could bolster your claim’s chances of success by preserving any and all records related to your treatment. Potential evidence could include, but is not limited to, the following:

1. Your Dupixent prescription;
2. Documentation showing that you used Dupixent for a certain period of time;
3. Your medical records, including records of misdiagnoses and failed treatments;
4. Reports showing that you were diagnosed with cutaneous T-cell lymphoma or a subset thereof; and
5. Paystubs and financial receipts documenting the financial losses you suffered during treatment.

In all probability, you will need more complex evidence to actually win your case. This is because pharmaceutical companies like Sanofi and Regeneron, the makers of Dupixent, will rarely settle a cancer lawsuit unless they are confronted by compelling evidence. Aside from your medical records, you may need to subpoena the defendants’ internal communications, review jargon-riddled literature, and consult expert medical witnesses.

Your personal injury lawyer will help you sort through the evidence you already have and determine what else you will need to negotiate a settlement or prevail at trial.

You need hard evidence to win a lawsuit, but your subjective experiences could influence your recovery. If you have been diagnosed with cutaneous T-cell lymphoma, you should:

1. Document your symptoms;
2. Track your feelings and pain levels in a dedicated journal; and
3. Speak to a therapist about how your diagnosis has affected your mental health.

Most personal injury lawsuits involve a request for two separate categories of damages: your economic damages and your non-economic damages. Economic damages reflect your verifiable financial losses, which are where pay stubs and collected receipts typically come into play. Non-economic damages, in contrast, compensate less-tangible forms of pain and suffering.

Although you cannot prove non-economic damages in the same way that you can prove economic loss, putting aside some time to reflect on your feelings, your level of physical pain, or the psychological repercussions of receiving a potentially life-altering diagnosis could make securing a holistic settlement substantially easier than it would otherwise be.

Pharmaceutical companies like Sanofi and Regeneron make billions of dollars each year.

These companies know that a problem with one of their most popular products could come at a massive cost. Instead of carefully reviewing your evidence and attempting to negotiate a settlement in good faith, they will often prioritize profits to the detriment of all else. They know that settling a lawsuit or losing in a trial could set a precedent, and they will almost always do everything in their power to avoid either outcome. Furthermore, since many pharmaceutical companies have near-limitless resources, they may simply try to wear you down in court, hoping you will eventually run out of both money and resolve.

You do not have to take your chances with a system that all too often favors money over merit.

For more than 30 years, the Dietrich Law Firm P.C. has fought to protect the rights of families in and around New York City. We know what it takes to build a strong, compelling case for compensation, the kind of case that will turn the tables during settlement negotiations or at trial.

Since our founding, we have secured more than $300 million in damages. We could help you, too. Please send us a message online or call us today at 1-866-529-5334 to speak to an NYC Dupixent injury lawyer and schedule your 100% free, no-obligation consultation as soon as possible.

Call the Dietrich Law Firm P.C. immediately at 1-866-529-5334 so that our aggressive, tenacious, and hardworking personal injury lawyers can fight to obtain the best result for your personal injury claim in New York, New York. We are available 24 hours a day, 7 days a week, and there is never a fee until we WIN for you!